Actively Recruiting

Phase Not Applicable
Age: 18Years - 120Years
All Genders
NCT06472128

Novel Digital Application for Patients With Acute Leukemia

Led by Massachusetts General Hospital · Updated on 2025-11-10

200

Participants Needed

3

Research Sites

288 weeks

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research study is evaluating to examine the efficacy of a novel a self-administered digital application (DREAMLAND) for improving patients' long-term quality of life and psychological outcomes for patients with acute myeloid leukemia undergoing intensive chemotherapy.

CONDITIONS

Official Title

Novel Digital Application for Patients With Acute Leukemia

Who Can Participate

Age: 18Years - 120Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Hospitalized patients over 18 years old diagnosed with acute myeloid leukemia (AML)
  • Starting intensive chemotherapy (7+3 or similar) or hypomethylating agents (HMA) with or without additional agents
  • Able to understand and speak English as the apps are only available in English
  • Includes newly diagnosed and relapsed/refractory AML patients starting intensive or HMA-based treatment
Not Eligible

You will not qualify if you...

  • Diagnosis of acute promyelocytic leukemia
  • Acute or unstable psychiatric or cognitive conditions that prevent informed consent or compliance with study procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Massachusetts General Hospital (MGH)

Boston, Massachusetts, United States, 02114

Actively Recruiting

2

Duke University

Durham, North Carolina, United States, 27710

Not Yet Recruiting

3

Fred Hutchinson Cancer Research Center (FHCRC)

Seattle, Washington, United States, 98109

Not Yet Recruiting

Loading map...

Research Team

A

Areej El-Jawahri, MD

CONTACT

U

Upeka Samarakoon, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here